Reset
Id
Protein
PTM type
Site
Species
Disease
Cell line
Drug
Regulatory
Confidence score(level)
Ref.
acc2501 Cdc2 phosphorylation Tyr15 human Ovarian Cancer HT29 Radiation Impairing 4.5 (High) 11719452
acc2502 Cdc2 phosphorylation Thr14 human Colorectal Cancer HT29 Radiation Impairing 4.5 (High) 11719452
acc2503 GSK3beta phosphorylation Ser9 human Endometrial Cancer RL95-2 Cisplatin Impairing 5.0 (High) 33680959
acc2504 GSK3beta phosphorylation Ser9 human Endometrial Cancer ARK-2 Cisplatin Impairing 5.0 (High) 33680959
acc2505 PKCepsilon phosphorylation Ser87 human Breast Cancer MCF7 4-OHE2 Associated 4.0 (Moderate) 31493422
acc2506 PKCepsilon phosphorylation Ser87 human Breast Cancer MDA-MB-231 4-OHE2 Associated 4.0 (Moderate) 31493422
acc2507 PKCepsilon phosphorylation Ser87 human Cervical Cancer HeLa 4-OHE2 Associated 4.0 (Moderate) 31493422
acc2508 PKCepsilon phosphorylation Ser87 human Prostate Cancer PC3 4-OHE2 Associated 4.0 (Moderate) 31493422
acc2509 UVRAG phosphorylation Ser522 human Hepatocellular Carcinoma MHCC97H D4476 Associated 4.0 (Moderate) 30686098
acc2510 UVRAG phosphorylation Ser522 human Hepatocellular Carcinoma HuH-7 D4476 Associated 4.0 (Moderate) 30686098
acc2511 UVRAG ubiquitination Lys517 human Hepatocellular Carcinoma MHCC97H D4476 Associated 4.0 (Moderate) 30686098
acc2512 UVRAG ubiquitination Lys517 human Hepatocellular Carcinoma HuH-7 D4476 Associated 4.0 (Moderate) 30686098
acc2513 UVRAG ubiquitination Lys559 human Hepatocellular Carcinoma MHCC97H D4476 Associated 4.0 (Moderate) 30686098
acc2514 UVRAG ubiquitination Lys559 human Hepatocellular Carcinoma HuH-7 D4476 Associated 4.0 (Moderate) 30686098
acc2515 ITGalpha6 S-nitrosylation Cys86 human Prostate Cancer PC3 1400W(iNOS inhibitors) Associated 4.0 (Moderate) 23106339
acc2516 ITGalpha6 S-nitrosylation Cys86 human Prostate Cancer DU145 1400W(iNOS inhibitors) Associated 4.0 (Moderate) 23106339
acc2517 SOX10 sumoylation Lys55 human Melanoma Vemurafenib Impairing 5.0 (High) 34087780
acc2518 LIP ubiquitination unclear mouse Mesothelioma AB1 Cisplatin Enhancing 5.0 (High) 29748013
acc2519 LIP ubiquitination unclear human Mesothelioma Cisplatin Enhancing 5.0 (High) 29748013
acc2520 PD-L1 ubiquitination unclear human Lung Cancer A549 DHA Associated 4.0 (Moderate) 36309154
acc2521 PD-L1 ubiquitination unclear mouse Lung Cancer LLC DHA Associated 4.0 (Moderate) 36309154
acc2522 PD-L1 ubiquitination unclear human Hepatocellular Carcinoma HepG2 DHA Associated 4.0 (Moderate) 36309154
acc2523 PD-L1 ubiquitination unclear human Hepatocellular Carcinoma SMMC-7721 DHA Associated 4.0 (Moderate) 36309154
acc2524 Stathmin phosphorylation Ser38 human Ovarian Cancer RMG-1 Paclitaxel Impairing 5.0 (High) 36328498
acc2525 HER2 ubiquitination unclear human Breast Cancer SK-BR-3 Peptide p37 Associated 4.0 (Moderate) 25898135
acc2526 HER2 ubiquitination unclear human Breast Cancer BT474 Peptide p37 Associated 4.0 (Moderate) 25898135
acc2527 HER2 ubiquitination unclear human Breast Cancer ZR-75-30 Peptide p37 Associated 4.0 (Moderate) 25898135
acc2528 HER2 ubiquitination unclear human Breast Cancer MDA-MB-361 Peptide p37 Associated 4.0 (Moderate) 25898135
acc2529 HER2 ubiquitination unclear human Breast Cancer SK-BR-3 Peptide p37 + Trastuzumab Associated 4.0 (Moderate) 25898135
acc2530 JNK2 phosphorylation unclear human Colorectal Cancer HT29 TRAIL + 5-fluorouracil (5-FU) Enhancing 5.0 (High) 15837763
acc2531 JNK2 phosphorylation unclear human Colorectal Cancer HepG2 TRAIL + 5-fluorouracil (5-FU) Enhancing 5.0 (High) 15837763
acc2532 AMPK phosphorylation Thr172 human Hepatocellular Carcinoma HepG2 Berberine Associated 3.0 (Low) 16508037
acc2533 AMPK phosphorylation Thr183 human Hepatocellular Carcinoma HepG2 Berberine Associated 3.0 (Low) 16508037
acc2534 Nrf2 phosphorylation unclear human Neuroblastoma IMR-32 DMAT(CK2 inhibitor) Associated 4.0 (Moderate) 18273910
acc2535 MRP3 nitration unclear human Colorectal Cancer HT29 Doxorubicin Enhancing 5.0 (High) 18922976
acc2536 MRP3 nitration unclear human Colorectal Cancer HT29-dx Doxorubicin Enhancing 5.0 (High) 18922976
acc2537 AKT phosphorylation Thr308 human Colorectal Cancer HT29 SBA Associated 4.0 (Moderate) 20503249
acc2538 AKT phosphorylation Ser473 human Colorectal Cancer HT29 SBA Associated 4.0 (Moderate) 20503249
acc2539 STAT3 phosphorylation Tyr705 human Hepatocellular Carcinoma Hep3B XZH-5 Impairing 4.0 (Moderate) 21311975
acc2540 STAT3 phosphorylation Tyr705 human Hepatocellular Carcinoma HepG2 XZH-5 Impairing 4.0 (Moderate) 21311975
acc2541 STAT3 phosphorylation Tyr705 human Hepatocellular Carcinoma HuH-7 XZH-5 Impairing 4.0 (Moderate) 21311975
acc2542 STAT3 phosphorylation Tyr705 human Hepatocellular Carcinoma SNU-387 XZH-5 Impairing 4.0 (Moderate) 21311975
acc2543 STAT3 phosphorylation Tyr705 human Hepatocellular Carcinoma SNU-398 XZH-5 Impairing 4.0 (Moderate) 21311975
acc2544 MKP-1 S-nitrosylation Cys258 human Head and Neck Cancer MDA-1483 Radiotherapy Impairing 4.5 (High) 22014408
acc2545 MKP-1 S-nitrosylation Cys258 human Head and Neck Cancer UM-SCC-10A Radiotherapy Impairing 4.5 (High) 22014408
acc2546 THOC5 phosphorylation Tyr225 human Leukemia K562 Dasatinib Enhancing 5.0 (High) 23032722
acc2547 THOC5 phosphorylation Tyr225 human Leukemia K562 Imatinib Enhancing 5.0 (High) 23032722
acc2548 THOC5 phosphorylation Tyr225 human Leukemia K562 Nilotinib Enhancing 5.0 (High) 23032722
acc2549 ITGalpha6 S-nitrosylation Cys86 human Prostate Cancer PC3 1400W(iNOS inhibitors) Enhancing 5.0 (High) 23106339
acc2550 AKT phosphorylation Thr308 human Neuroblastoma SK-N-SH neuroblastoma cells Okadaic acid Enhancing 4.0 (Moderate) 23127854